Trial intelligence / Profile preview

COMPELL: Niaspan Combinations vs Other Lipid Therapies in Dyslipidemia

NCT00079638Phase 4Completed

Sponsor
Kos Pharmaceuticals, Inc.
Start
Apr 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of niacin in dyslipidemia, sponsored by Kos Pharmaceuticals, Inc.. Started Apr 2004; status: completed.

02

Drugs

niacin
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT00079638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00079638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call